Related Experiment Video
Updated: Jun 30, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Before Birth, Beyond Childhood: Understanding the Influence of Prenatal Substance Exposure on Psychiatric Diagnoses
Insights
Prenatal substance exposure (PSE) increases the risk for childhood psychiatric diagnoses. Higher numbers of exposures correlate with greater odds of anxiety, behavioral, substance use, and mood disorders.
Area of Science:
- Child Psychology
- Developmental Psychiatry
- Public Health
Background:
- Prenatal substance exposure (PSE) occurs during fetal development.
- PSE can lead to long-term mental health issues in children.
- The relationship between PSE and psychiatric diagnoses requires further investigation.
Purpose of the Study:
- To examine the association between prenatal substance exposure and childhood psychiatric diagnoses.
- To determine if exposure thresholds, cumulative effects, or individual substances are linked to specific diagnoses.
- To quantify the odds ratios for psychiatric diagnoses based on PSE levels.
Main Methods:
- Utilized electronic health records from the University of Minnesota Adoption Medicine Clinic.
- Identified PSE through caregiver narratives, child protective services, and toxicology reports.
- Employed logistic regression to analyze exposure thresholds, cumulative counts, and individual substances against psychiatric diagnoses.
Main Results:
- Psychiatric diagnoses significantly increased with the number of prenatal substance exposures.
- Anxiety Disorders showed elevated odds with increasing PSE, from OR 1.47 (1 exposure) to OR 2.03 (≥4 exposures).
- Cumulative exposure was linked to Anxiety, Behavioral/Emotional, Substance Use, and Mood Disorders; alcohol, tobacco, and marijuana were individually associated with diagnoses.
Conclusions:
- Increasing prenatal substance exposure is associated with higher odds of psychiatric diagnoses.
- The specific patterns of association vary by substance and psychiatric outcome.
- Findings highlight the need for research into exposure timing and combinations for early intervention.
Background:
Prenatal substance exposure (PSE) occurs when an individual is exposed to substances in utero. PSEs may have lasting effects on mental health. We tested whether PSEs show threshold, cumulative, or individual substance associations with childhood psychiatric diagnoses.
Methods:
Clinical variables (demographics, ICD-9/10 diagnoses, PSE history) were extracted from electronic health records from the University of Minnesota Adoption Medicine Clinic. PSEs were identified from caregiver and child-protective-services narratives and/or toxicology (cord tissue/blood, meconium). For each ICD-9/10 diagnostic category, we fit logistic regression models comparing (1) exposure thresholds (0, 1, 2, 3, ≥4 exposures), (2) a cumulative exposure count, and (3) individual substances to estimate marginal odds ratios (ORs) with 95% Confidence Intervals (CIs).
Results:
Psychiatric diagnoses increased with the number of PSEs. Relative to no exposure, odds of an Anxiety Disorder rose from OR 1.47 (95% CI 1.16-1.87) with one exposure to OR 2.03 (1.64-2.52) with ≥4 exposures. Higher cumulative exposure scores were associated with Anxiety Disorders (OR 1.28, 1.18-1.38), Behavioral and Emotional Disorders (OR 1.42, 1.31-1.54), Substance Use Disorders (OR 1.52, 1.29-1.79), and Mood Disorders (OR 1.16, 1.04-1.30). Alcohol, tobacco, and marijuana exposures were associated with increased odds of at least one psychiatric diagnosis, and each substance showed at least one significant diagnostic cluster when modeled independently.
Conclusion:
Increasing numbers of PSEs were associated with higher odds of psychiatric diagnoses, with patterns varying by substance and outcome. These findings motivate research on exposure timing and combinations to support earlier identification and intervention for at-risk children.
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Teratogenicity
Psychological and Sociocultural Causes of Schizophrenia
